![Francesco Galimi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francesco Galimi
Directeur Technique/Scientifique/R&D chez ADICET BIO, INC.
Fortune : 123 179 $ au 30/06/2024
Postes actifs de Francesco Galimi
Sociétés | Poste | Début | Fin |
---|---|---|---|
ADICET BIO, INC. | Directeur Technique/Scientifique/R&D | 01/09/2019 | - |
Adicet Therapeutics, Inc.
![]() Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Directeur Technique/Scientifique/R&D | 01/09/2019 | - |
Historique de carrière de Francesco Galimi
Anciens postes connus de Francesco Galimi
Sociétés | Poste | Début | Fin |
---|---|---|---|
AMGEN INC. | Corporate Officer/Principal | 01/01/2015 | 01/01/2019 |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/01/2014 | 01/01/2015 |
ADICET BIO, INC. | Directeur Technique/Scientifique/R&D | 15/09/2020 | - |
Formation de Francesco Galimi
University of Turin | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Italie | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ADICET BIO, INC. | Health Technology |
AMGEN INC. | Health Technology |
Entreprise privées | 3 |
---|---|
resTORbio, Inc.
![]() resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
Adicet Therapeutics, Inc.
![]() Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Bourse
- Insiders
- Francesco Galimi
- Expérience